Findings linked with inhaled corticosteroids

Inhaled steroids are medicines that are taken in case of asthma by kids and adults. Persons that have mild, moderate and severe asthma use these medicines daily. These medications prevent inflammation of the airways. Doctors supervise persons with this disease, adjusting dosage schedule each 6 weeks.
Unfortunately, inhaled steroids, like other medications, may cause negative consequences. Regular application of these medications is connected with some risks. Is there any way for individuals with asthma to avoid these problems?
A recent research has displayed that prescribers should not recommend taking these products daily to individuals with mild-to-moderate asthma. This study turned out to be very valuable. It is likely to alter guidelines connected with treatment of asthma.
The research was conducted by specialists of the Texas Medical Brach in Galveston. The physician William Calhoun and his colleagues enrolled 340 persons with asthma in the research. Several persons received inhaled steroids daily; others took these preparations, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the specialists during nine months. The results of the research manifested that there was not any essential difference between these two groups.
According to the specialists, if inhaled steroids are taken, when symptoms occur, exacerbation can be prevented. Moreover, these preparations have prolonged action. It means that positive effects are felt even some days after application. The scientists suggest that these medicines may be taken by individuals with mild-to-moderate asthma only when symptoms appear.
Why is this study valuable? According to certain sources, 25 million Americans suffer from asthma. Undoubtedly, they should be treated. This piece of news must be valuable for them. Moreover, if inhaled corticosteroids are administered prolonged period of time, they may cause severe adverse reactions, such as hormonal imbalance, cataract, etc. Thus, if individuals that suffer from mild-to-moderate asthma don’t administer these drugs each day, they are more unlikely to get these adverse effects.
Undoubtedly, it is early to modify guidelines linked with treatment of asthma. But this study may promote conducting further studies that may lead to some changes.